Today, a meeting of the working group dedicated to organizing the international forum titled “Combating Transnational Drug Threats: Health, Security, and Sustainable Development” was held at the Agency for the Control of Narcotics and Firearms under the Administration of the President of the Republic of Uzbekistan.

An important regulatory legal act aimed at ensuring the safety and quality of medicinal products has been adopted in the Republic of Uzbekistan. In particular, by Order No. 26 of the Minister of Health of the Republic of Uzbekistan dated December 22, 2025, the “Regulation on the Procedure for Conducting Clinical Studies on the Pharmacokinetic Bioequivalence of Generic Medicinal Products and Evaluation of Their Results” was approved and registered with the Ministry of Justice (registration number — 3750).

In order to ensure uninterrupted access of the population to essential medicinal products and medical devices, an important regulatory legal act has been adopted. By Order No. 24 of the Minister of Health of the Republic of Uzbekistan dated January 5, 2026, a procedure was approved allowing the use in medical practice and importation of medicinal products and medical devices experiencing temporary shortages without state registration, subject to mandatory certification.

By Order No. 16 of the Minister of Health of the Republic of Uzbekistan dated December 24, 2025, the “Rules for the Nomenclature Classification of Medical Devices by Types and Their Classification According to the Level of Risk of Use” were approved and registered with the Ministry of Justice (registration number — No. 3751 dated January 12, 2026).

In the Republic of Uzbekistan, an important regulatory legal act aimed at protecting the life and health of the population during the use of medicinal products and medical devices has been adopted. By Order No. 18 of the Minister of Health of the Republic of Uzbekistan dated December 30, 2025, the “Regulation on the Procedure for Pharmacovigilance of Medicinal Products and Safety Monitoring of Medical Devices” was approved and registered with the Ministry of Justice (registration number — No. 3752 dated Jan

In cooperation between the Center for Safety of Pharmaceutical Products and the International Pharmaceutical Regulators Programme (IPRP), a number of important events aimed at harmonizing international approaches to the assessment of the quality and bioequivalence of medicinal products are planned.

In order to ensure the implementation of the Law of the Republic of Uzbekistan “On Medicines and Pharmaceutical Activities,” as well as the Presidential Decree of the Republic of Uzbekistan dated August 19, 2025, No. PF–137 “On Additional Measures to Regulate the Circulation of Medicines and Medical Devices,” four important regulatory legal documents in the field of pharmaceuticals and medical technologies were approved last week by relevant orders of the Ministry of Health.

The Metrology Service of the Ministry of Health regularly carries out planned activities to assess the condition of medical measuring instruments and to verify them in accordance with established procedures in private medical institutions across the republic.

Within the framework of scientific research aimed at ensuring the quality and safety of locally produced medicinal products, a dissertation devoted to the development of standardization and quality control methods for the medicinal product “Ekustim” has been presented.

In carrying out quality control of medicinal products and medical devices in the Republic of Uzbekistan, priority is given to the general pharmacopoeial monographs, pharmacopoeial monographs and testing methods established in the State Pharmacopoeia of the Republic of Uzbekistan.